259 related articles for article (PubMed ID: 17826918)
41. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
[TBL] [Abstract][Full Text] [Related]
42. Older and stronger object memories are selectively destabilized by reactivation in the presence of new information.
Winters BD; Tucci MC; DaCosta-Furtado M
Learn Mem; 2009 Sep; 16(9):545-53. PubMed ID: 19713353
[TBL] [Abstract][Full Text] [Related]
43. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task.
Monteiro Moreira K; Lima Ferreira T; Vecchio Fornari R; Perez Figueredo LZ; Menezes Oliveira MG
Brain Res Bull; 2005 Nov; 67(6):504-8. PubMed ID: 16216700
[TBL] [Abstract][Full Text] [Related]
44. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
[TBL] [Abstract][Full Text] [Related]
45. NMDA receptors interact with the retrieval memory enhancing effect of pioglitazone in mice.
Almasi-Nasrabadi M; Gharedaghi MH; Rezazadeh P; Dehpour AR; Javadi-Paydar M
Pharmacol Biochem Behav; 2014 Nov; 126():136-45. PubMed ID: 25284130
[TBL] [Abstract][Full Text] [Related]
46. Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats.
Tikhonravov D; Neuvonen T; Pertovaara A; Savioja K; Ruusuvirta T; Näätänen R; Carlson S
Brain Res; 2008 Apr; 1203():97-102. PubMed ID: 18325485
[TBL] [Abstract][Full Text] [Related]
47. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.
Nilsson M; Carlsson A; Markinhuhta KR; Sonesson C; Pettersson F; Gullme M; Carlsson ML
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):677-85. PubMed ID: 15276693
[TBL] [Abstract][Full Text] [Related]
48. Effects of acute stress and GluN2B-containing NMDA receptor antagonism on object and object-place recognition memory.
Howland JG; Cazakoff BN
Neurobiol Learn Mem; 2010 Feb; 93(2):261-7. PubMed ID: 19857581
[TBL] [Abstract][Full Text] [Related]
49. Pre-training administration of anesthetic ketamine differentially affects rats' spatial and non-spatial recognition memory.
Pitsikas N; Boultadakis A
Neuropharmacology; 2009 Jul; 57(1):1-7. PubMed ID: 19376140
[TBL] [Abstract][Full Text] [Related]
50. Effects of neonatal repeated MK-801 treatment on delayed nonmatching-to-position responses in rats.
Kawabe K; Miyamoto E
Neuroreport; 2008 Jun; 19(9):969-73. PubMed ID: 18521003
[TBL] [Abstract][Full Text] [Related]
51. The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice.
Rogóż Z; Kamińska K
Pharmacol Rep; 2016 Feb; 68(1):116-20. PubMed ID: 26721362
[TBL] [Abstract][Full Text] [Related]
52. D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
Matsuoka N; Aigner TG
J Pharmacol Exp Ther; 1996 Aug; 278(2):891-7. PubMed ID: 8768744
[TBL] [Abstract][Full Text] [Related]
53. Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats.
Li JT; Su YA; Guo CM; Feng Y; Yang Y; Huang RH; Si TM
Eur J Pharmacol; 2011 Feb; 652(1-3):65-72. PubMed ID: 21114996
[TBL] [Abstract][Full Text] [Related]
54. Guanosine possesses specific modulatory effects on NMDA receptor-mediated neurotransmission in intact mice.
Deutsch SI; Rosse RB; Long KD; Gaskins BL; Mastropaolo J
Eur Neuropsychopharmacol; 2008 Apr; 18(4):299-302. PubMed ID: 17804205
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse.
Nilsson M; Markinhuhta KR; Carlsson ML
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):521-30. PubMed ID: 16414166
[TBL] [Abstract][Full Text] [Related]
56. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine.
Matsuoka N; Aigner TG
J Pharmacol Exp Ther; 1997 Mar; 280(3):1201-9. PubMed ID: 9067304
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
58. Assessment of sustained attention in ad libitum fed Wistar rats: effects of MK-801.
Slawecki CJ; Roth J
Physiol Behav; 2005 Jun; 85(3):346-53. PubMed ID: 15932764
[TBL] [Abstract][Full Text] [Related]
59. Repeated treatment with the NMDA antagonist MK-801 disrupts reconsolidation of memory for amphetamine-conditioned place preference.
Sadler R; Herzig V; Schmidt WJ
Behav Pharmacol; 2007 Nov; 18(7):699-703. PubMed ID: 17912055
[TBL] [Abstract][Full Text] [Related]
60. On the delay-dependent involvement of the hippocampus in object recognition memory.
Hammond RS; Tull LE; Stackman RW
Neurobiol Learn Mem; 2004 Jul; 82(1):26-34. PubMed ID: 15183168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
